Akebia Therapeutics shares owned by Wells Fargo & Company
Quarter-by-quarter ownership of Akebia Therapeutics (AKBA) shares owned by Wells Fargo & Company
from 13F filings
Historical chart of Wells Fargo & Company investment in Akebia Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Akebia Therapeutics held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Akebia Therapeutics by Wells Fargo & Company
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-03-31 | $15k | 8.0k | 1.83 |
| 2023-12-31 | $14k | 11k | 1.24 |
| 2023-09-30 | $13k | 11k | 1.14 |
| 2023-06-30 | $10k | 11k | 0.92 |
| 2022-12-31 | $7.8k | 14k | 0.58 |
| 2022-09-30 | $0 | 14k | 0.00 |
| 2022-06-30 | $4.7k | 15k | 0.32 |
| 2022-03-31 | $212k | 296k | 0.72 |
| 2021-12-31 | $786k | 348k | 2.26 |
| 2021-09-30 | $605k | 146k | 4.15 |
| 2021-06-30 | $82k | 20k | 4.15 |
| 2021-03-31 | $367k | 108k | 3.39 |
| 2020-12-31 | $729k | 261k | 2.80 |
| 2020-09-30 | $782k | 312k | 2.51 |
| 2020-06-30 | $4.2M | 306k | 13.58 |
| 2020-03-31 | $1.8M | 242k | 7.58 |
| 2019-12-31 | $1.3M | 202k | 6.32 |
| 2019-09-30 | $797k | 204k | 3.91 |
| 2019-06-30 | $820k | 169k | 4.84 |
| 2019-03-31 | $1.2M | 149k | 8.18 |
| 2018-12-31 | $877k | 159k | 5.53 |
| 2018-09-30 | $694k | 79k | 8.83 |
| 2018-06-30 | $1.2M | 120k | 9.99 |
| 2018-03-31 | $1.1M | 114k | 9.53 |
| 2017-12-31 | $1.8M | 121k | 14.86 |
| 2017-06-30 | $1.3M | 88k | 14.36 |
| 2017-03-31 | $803k | 87k | 9.20 |
| 2016-12-31 | $926k | 89k | 10.40 |
| 2016-09-30 | $763k | 84k | 9.07 |
| 2016-06-30 | $620k | 83k | 7.46 |
| 2016-03-31 | $782k | 87k | 8.98 |
| 2015-12-31 | $1.2M | 92k | 12.87 |
| 2015-09-30 | $128k | 13k | 9.60 |
| 2015-03-31 | $91k | 8.1k | 11.17 |
| 2014-12-31 | $77k | 7.0k | 11.02 |
| 2014-06-30 | $93k | 3.5k | 26.93 |